Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
BMC Cancer
|
June 7, 2022
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib
James C H Yang, Marcia S Brose, Gilberto Castro, et al.
The Oncologist
|
December 10, 2020
Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors
Cissimol P Joseph, Sarah N Abaricia, Michelle A Angelis, et al.
Journal for Immunotherapy of Cancer
|
August 16, 2023
Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden
Vaia Florou, Charalampos S Floudas, Asaf Maoz, et al.
Annals of Surgical Oncology
|
October 31, 2006
Surgical resection of gastrointestinal stromal tumors after treatment with imatinib
Robert H I Andtbacka, Chaan S Ng, Courtney L Scaife, et al.
The Journal of Clinical Investigation
|
December 7, 2007
An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic
Ariel Fernández, Angela Sanguino, Zhenghong Peng, et al.
Cancers
|
March 6, 2021
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)
Bernd Kasper, Annie Achee, Kathrin Schuster, et al.
The Oncologist
|
January 16, 2021
Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy
Suzanne George, Robin L Jones, Sebastian Bauer, et al.
Cancer
|
November 15, 2024
Sorafenib or anthracycline-based chemotherapy for progressive desmoid tumors
Philippos Apolinario Costa, Arshia Arora, Yannelys Fernandez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2022
Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial
Sebastian Bauer, Robin L Jones, Jean-Yves Blay, et al.
Leukemia Research
|
November 28, 2017
Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study
Ronan T Swords, Diana Azzam, Hassan Al-Ali, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
BMC Cancer
|
June 7, 2022
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib
James C H Yang, Marcia S Brose, Gilberto Castro, et al.
The Oncologist
|
December 10, 2020
Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors
Cissimol P Joseph, Sarah N Abaricia, Michelle A Angelis, et al.
Journal for Immunotherapy of Cancer
|
August 16, 2023
Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden
Vaia Florou, Charalampos S Floudas, Asaf Maoz, et al.
Annals of Surgical Oncology
|
October 31, 2006
Surgical resection of gastrointestinal stromal tumors after treatment with imatinib
Robert H I Andtbacka, Chaan S Ng, Courtney L Scaife, et al.
The Journal of Clinical Investigation
|
December 7, 2007
An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic
Ariel Fernández, Angela Sanguino, Zhenghong Peng, et al.
Cancers
|
March 6, 2021
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)
Bernd Kasper, Annie Achee, Kathrin Schuster, et al.
The Oncologist
|
January 16, 2021
Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy
Suzanne George, Robin L Jones, Sebastian Bauer, et al.
Cancer
|
November 15, 2024
Sorafenib or anthracycline-based chemotherapy for progressive desmoid tumors
Philippos Apolinario Costa, Arshia Arora, Yannelys Fernandez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2022
Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial
Sebastian Bauer, Robin L Jones, Jean-Yves Blay, et al.
Leukemia Research
|
November 28, 2017
Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study
Ronan T Swords, Diana Azzam, Hassan Al-Ali, et al.
Page
of 8